Taiwan Biopharma Excellence Awards 2024
The Taiwan Biopharma Excellence Awards celebrate the achievements of biopharma experts/organizations in Taiwan and East Asia who have made remarkable advancements in biopharmaceutical research, bioprocessing, and vaccine development throughout the years. This year, the ceremony is held in conjunction with the highly anticipated 12th Biologics World Taiwan.
Taiwan Biopharma Excellence Awards 2024
Taiwan Biopharma Excellence Awards 2024 seeks to give recognition to exceptional bioprocessing & research experts, organization and technologies that facilitate biomanufacturing and research innovation excellence at enhanced speed, reduced cost and superior quality. Featuring top bioprocessing and research leaders in the Taiwan industry, along with the latest advances in technologies, best practices in manufacturing and disruptive innovation in R&D, Taiwan Biopharma Excellence Awards applaud extraordinary leaders & trend-setters of today, and inspire innovators of tomorrow.
The award ceremony will be held in conjunction with the 12th Biologics World Taiwan 2024 happening on 23rd to 24th October 2024 which attracts more than 300 representatives from Taiwan top biopharmas, vaccine manufacturers and biologics companies.
Nominate an organization/individual now till 10th May:
Important event information
Taiwan Biopharma Excellence Awards 2024
6:00 PM – 7:30 PM
23rd October 2024
Taipei, Taiwan (TBC)
- Form valuable connections with established biopharma companies in Taiwan and East Asia.
- Gain unique insights from Awards Winners in order to build your own company’s efforts in the biopharma space
- Enjoy cocktails and dinner while networking in a relaxed atmosphere.
Taiwan Biopharma Excellence Awards (台灣生物製藥卓越獎)
- Upstream Processing (最佳生物製藥供應 商：上遊)
- Downstream Processing (最佳生物製藥供應 商：下遊)
- Fill-Finish & Packaging (最佳生物製藥供應 商：製劑與包裝)
- Viral Clearance & Filtration (最佳生物製藥供應 商：病毒清除 & 過 濾)
- Best Contract Development & Manufacturing Organization [CDMO] Award (最佳生技藥品委託研發生產機構)
- Best Contract Research Organization Award (最佳生技藥品委託研究機構)
- Overall Bioprocessing Supplier Award (年度最佳生物製藥供應商)
- Best Bioprocessing Innovation of the Year (年度最佳生物製藥創新技術獎)
- Best Platform Technology Award (最佳技術平台獎)
- Best Vaccines Development Award (最佳疫苗研發獎)
- Best Monoclonal Antibody Development and Manufacturing Award (最佳单克隆抗体研發生產獎)
- Most Promising Monoclonal Antibodies Pipeline (最具潛力单克隆抗体 研發)
- Most Promising Immunotherapy Pipeline (最具潛力免疫治疗研發)
- Most Promising Stem Cell Therapy Pipeline (最具潛力干细胞疗法 研發)
- Best National Innovation Award in Academic Research and Discovery (最佳學術研發創新獎)
- Best Industrial Partnership (最佳技術合作)
- Company to Watch Out For In Taiwan (年度潛力獎)
- Lifetime Achievement Award (终身成就奖)
How does it work?
Taiwan Biopharma Excellence Awards 2024 seeks to give recognition to exceptional bioprocessing & research experts, organization and technologies that facilitate biomanufacturing and research innovation excellence at enhanced speed, reduced cost and superior quality. Featuring top bioprocessing and research leaders in the Taiwan industry, along with the latest advances in technologies, best practices in manufacturing and disruptive innovation in R&D, Taiwan Biopharma Excellence Awards applaud extraordinary leaders & trend-setters of today, and inspire innovators of tomorrow.
TIMELINE OF AWARDS
KBEA 2024 Sponsor
Become a Sponsor of KBEA 2024
As a sponsor, you’ll have an exclusive opportunity to connect directly with key stakeholders and gain marketing exposure to industry leaders, decision-makers, and professionals across the biologics, cell and gene therapy, and vaccine communities.
Take advantage of a comprehensive multichannel marketing campaign: before, during, and after the Awards. Each sponsorship package is meticulously crafted with a marketing blend to strategically position your company as a prominent entity in the biologics manufacturing, cell and gene therapy, and vaccine landscapes.
AWARDS CRITERIA
The criteria for a company to be eligible for the Taiwan Biopharma Excellence Awards (TBEA) 2024 are:
- Its involvement in the development and/or manufacturing of biologics, cell and gene therapy and vaccines
- Its notable presence in Taiwan or East Asia
- When nominated, there is sufficient justification of its significant developments in its respective field over the past few years
Based on the number of nominations and thorough assessment of each category’s nominees, the top 5-7 entries under each category will be shortlisted. The award winner will be determined by voting from the Biologics, Vaccine and Cell and Gene Therapy Manufacturing community. Companies with the highest number of votes will win the award in their respective category.
WHAT CAN YOU EXPECT?
CHOOSE YOUR PLAN
Select the Ticketing Option That Fits Your Needs
BOOK A TABLE
Our award can boost your company’s recognition and reputation, portraying innovation and adaptability. The awards give you the opportunity to showcase your technologies and get recognised for your achievements. We recognise and value outstanding achievements and technologies made by experts in the industry.
